MiNK Therapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $-53.9M | $2.7M |
| FY2021 | — | $23.8M | $38.9M |
| FY2022 | — | $-401.3K | $19.6M |
| FY2023 | — | $-18.1M | $3.4M |
| FY2024 | — | $-19.6M | $4.6M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $-53.9M | $2.7M |
| FY2021 | — | $23.8M | $38.9M |
| FY2022 | — | $-401.3K | $19.6M |
| FY2023 | — | $-18.1M | $3.4M |
| FY2024 | — | $-19.6M | $4.6M |